Is Insight Molecular Stock a Good Investment?
Insight Molecular Investment Advice | IMDX |
- Examine Insight Molecular's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Insight Molecular's leadership team and their track record. Good management can help Insight Molecular navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Insight Molecular's business and its evolving consumer preferences.
- Compare Insight Molecular's performance and market position to its competitors. Analyze how Insight Molecular is positioned in terms of product offerings, innovation, and market share.
- Check if Insight Molecular pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Insight Molecular's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Insight Molecular Diagnostics stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Insight Molecular Diagnostics is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Insight Molecular Stock
Researching Insight Molecular's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 22.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.79. Insight Molecular had not issued any dividends in recent years. The entity had 1:20 split on the 25th of July 2023.
To determine if Insight Molecular is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Insight Molecular's research are outlined below:
| Insight Molecular generated a negative expected return over the last 90 days | |
| Insight Molecular has high historical volatility and very poor performance | |
| Insight Molecular has a very high chance of going through financial distress in the upcoming years | |
| Insight Molecular Diagnostics was previously known as OncoCyte Corp and was traded on NASDAQ Exchange under the symbol OCX. | |
| The company reported the previous year's revenue of 1.88 M. Net Loss for the year was (60.66 M) with profit before overhead, payroll, taxes, and interest of 2.09 M. | |
| Insight Molecular generates negative cash flow from operations | |
| About 56.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Insight Molecular Diagnostics Insiders Placed Bullish Bets Worth US2.82m |
Earnings surprises can significantly impact Insight Molecular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Insight Molecular's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-09 | 2024-06-30 | -0.37 | -0.432 | -0.062 | 16 | ||
2024-11-13 | 2024-09-30 | -0.4367 | -0.98 | -0.5433 | 124 | ||
2025-03-25 | 2024-12-31 | -0.4 | -1.93 | -1.53 | 382 |
Insight Molecular's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 86.66 M.Market Cap |
|
Insight Molecular's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.96) | (2.81) | |
| Return On Capital Employed | (2.20) | (2.09) | |
| Return On Assets | (1.73) | (1.82) | |
| Return On Equity | 4.94 | 5.19 |
Determining Insight Molecular's profitability involves analyzing its financial statements and using various financial metrics to determine if Insight Molecular is a good buy. For example, gross profit margin measures Insight Molecular's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Insight Molecular's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Insight Molecular's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Insight Molecular Diagnostics. Check Insight Molecular's Beneish M Score to see the likelihood of Insight Molecular's management manipulating its earnings.
Evaluate Insight Molecular's management efficiency
Insight Molecular has return on total asset (ROA) of (0.2217) % which means that it has lost $0.2217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.2896) %, meaning that it created substantial loss on money invested by shareholders. Insight Molecular's management efficiency ratios could be used to measure how well Insight Molecular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 5.19 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (2.81). At this time, Insight Molecular's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 32.8 M in 2025, despite the fact that Return On Tangible Assets are likely to grow to (2.81).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.94) | (0.89) | |
| Tangible Book Value Per Share | (2.06) | (1.95) | |
| Enterprise Value Over EBITDA | (0.44) | (0.47) | |
| Price Book Value Ratio | (2.53) | (2.41) | |
| Enterprise Value Multiple | (0.44) | (0.47) | |
| Price Fair Value | (2.53) | (2.41) |
Management at Insight Molecular focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Beta 0.987 |
Basic technical analysis of Insight Stock
As of the 23rd of July, Insight Molecular retains the Downside Deviation of 4.51, risk adjusted performance of 0.0354, and Market Risk Adjusted Performance of (0.20). Insight Molecular technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Insight Molecular's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Insight Molecular insiders, such as employees or executives, is commonly permitted as long as it does not rely on Insight Molecular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Insight Molecular insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Last Andrew J. over two weeks ago Acquisition by Last Andrew J. of 35000 shares of Insight Molecular subject to Rule 16b-3 | ||
Andrews Ronald Asbury over three weeks ago Disposition of 93750 shares by Andrews Ronald Asbury of Insight Molecular subject to Rule 16b-3 | ||
Smith Patrick W over a month ago Acquisition by Smith Patrick W of 3880 shares of IMDX New at 2.01 subject to Rule 16b-3 |
Understand Insight Molecular's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Insight Molecular's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0354 | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 3.86 | |||
| Semi Deviation | 4.17 | |||
| Downside Deviation | 4.51 | |||
| Coefficient Of Variation | 3366.54 | |||
| Standard Deviation | 6.44 | |||
| Variance | 41.52 | |||
| Information Ratio | 0.002 | |||
| Jensen Alpha | 0.3244 | |||
| Total Risk Alpha | (1.02) | |||
| Sortino Ratio | 0.0029 | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 47.86 | |||
| Value At Risk | (6.27) | |||
| Potential Upside | 12.05 | |||
| Downside Variance | 20.36 | |||
| Semi Variance | 17.41 | |||
| Expected Short fall | (4.75) | |||
| Skewness | 2.66 | |||
| Kurtosis | 11.95 |
| Risk Adjusted Performance | 0.0354 | |||
| Market Risk Adjusted Performance | (0.20) | |||
| Mean Deviation | 3.86 | |||
| Semi Deviation | 4.17 | |||
| Downside Deviation | 4.51 | |||
| Coefficient Of Variation | 3366.54 | |||
| Standard Deviation | 6.44 | |||
| Variance | 41.52 | |||
| Information Ratio | 0.002 | |||
| Jensen Alpha | 0.3244 | |||
| Total Risk Alpha | (1.02) | |||
| Sortino Ratio | 0.0029 | |||
| Treynor Ratio | (0.21) | |||
| Maximum Drawdown | 47.86 | |||
| Value At Risk | (6.27) | |||
| Potential Upside | 12.05 | |||
| Downside Variance | 20.36 | |||
| Semi Variance | 17.41 | |||
| Expected Short fall | (4.75) | |||
| Skewness | 2.66 | |||
| Kurtosis | 11.95 |
Consider Insight Molecular's intraday indicators
Insight Molecular intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Insight Molecular stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Insight Molecular time-series forecasting models is one of many Insight Molecular's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Insight Molecular's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Insight Stock media impact
There is far too much social signal, news, headlines, and media speculation about Insight Molecular that are available to investors today. This information is accessible both publicly - through Insight Molecular's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Insight-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Insight Molecular news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Insight Molecular relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Insight Molecular's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Insight Molecular alpha.
Insight Molecular Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Insight Molecular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Insight Molecular Corporate Management
| Gabrielle Woody | Executive Assistant | Profile | |
| Andrea James | Chief Officer | Profile | |
| James Liu | Treasurer, Accounting | Profile | |
| Ekkehard MD | Chief Officer | Profile | |
| YuhMin Chiang | Chief Officer | Profile |
Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.